Although I live with a chronic illness, I’ve always tried to shape my life with as much freedom and independence as possible. This was true long before anyone put a name to my condition: IgG4‑RD. The ability to make my own choices and decide for myself how a day…
Regulatory authorities in Japan have granted orphan drug designation to rilzabrutinib, an oral therapy candidate for immunoglobulin G4-related disease (IgG4-RD) that’s now in late-stage clinical testing globally. In Japan, orphan drug designation is awarded to experimental medicines that aim to treat diseases affecting fewer than 50,000 people in the…
Discussion
Did you know that 1 in 6 people has a disability? Don’t worry if you didn’t, because about 80% of disabilities are invisible. Invisible or hidden disabilities are those that lack obvious or visible signs, such as using a cane or wheelchair, or having a noticeable physical difference.
Get regular updates to your inbox.
